Reviewed,
UniProtKB/Swiss-Prot P15531 (NDKA_HUMAN)
Last modified
June 16, 2009.
Version 114.
History...
Clusters with 100%,
90%,
50% identity |
Documents (7) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Nucleoside diphosphate kinase A Short name=NDP kinase A Short name=NDK A EC=2.7.4.6 Alternative name(s): Tumor metastatic process-associated protein Metastasis inhibition factor nm23 nm23-H1 Granzyme A-activated DNase Short name=GAAD | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 152 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Major role in the synthesis of nucleoside triphosphates other than ATP. Possesses nucleoside-diphosphate kinase, serine/threonine-specific protein kinase, geranyl and farnesyl pyrophosphate kinase, histidine protein kinase and 3'-5' exonuclease activities. Involved in cell proliferation, differentiation and development, signal transduction, G protein-coupled receptor endocytosis, and gene expression. Required for neural development including neural patterning and cell fate determination. Has tumor metastasis-suppressive capacity. |
| Catalytic activity | ATP + nucleoside diphosphate = ADP + nucleoside triphosphate. |
| Cofactor | Magnesium. |
| Enzyme regulation | Autophosphorylation at His-118 increases serine/threonine protein kinase activity of the enzyme. Interaction with the SET complex inhibits exonuclease activity. |
| Subunit structure | Hexamer of two different chains: A and B (A6, A5B, A4B2, A3B3, A2B4, AB5, B6). Interacts with SET and PRUNE. Ref.2 Ref.15 Ref.18 |
| Subcellular location | Cytoplasm. Nucleus. Note: Cell-cycle dependent nuclear localization which can be induced by interaction with Epstein-barr viral proteins or by degradation of the SET complex by GzmA. Ref.16 |
| Tissue specificity | Isoform 1 is expressed in heart, brain, placenta, lung, liver, skeletal muscle, pancreas, spleen and thymus. Expressed in lung carcinoma cell lines but not in normal lung tissues. Isoform 2 is ubiquitously expressed and its expression is also related to tumor differentiation. Isoform 3 is ubiquitously expressed. Ref.16 Ref.5 Ref.14 |
| Post-translational modification | The N-terminus is blocked. |
| Involvement in disease | This protein is found in reduced amount in tumor cells of high metastatic potential. Somatic mutations of NME1 are found in neuroblastoma. Increased NME1 in neuroblastoma is correlated with features of the disease that are associated with aggressive tumors. May therefore have distinct if not opposite roles in different tumors. Ref.11 |
| Sequence similarities | Belongs to the NDK family. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| itself | 2 | EBI-741141,EBI-741141 | ||
| Ksr1 | Q61097 | 2 | EBI-741141,EBI-1536336 | From a different organism. |
| MCF2 | P10911 | 4 | EBI-741141,EBI-1914514 | |
| NME2 | P22392 | 1 | EBI-741141,EBI-713693 | |
| PRUNE | Q86TP1 | 1 | EBI-741141,EBI-2127112 | |
| STRAP | Q9Y3F4 | 6 | EBI-741141,EBI-727414 |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P15531-1) Also known as: NM23-H1A; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P15531-2) Also known as: NM23-H1B; The sequence of this isoform differs from the canonical sequence as follows: 1-1: M → MVLLSTLGIVFQGEGPPISSCDTGTM | ||||||
| Isoform 3 (identifier: P22392-2) Also known as: NM23-LV; The sequence of this isoform can be found in the external entry P22392-2. Isoforms of the same protein are often annotated in two different entries if their sequences differ significantly. | ||||||
| Note: Based on a naturally occurring readthrough transcript which produces an NME1-NME2 fusion protein. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 152 | 152 | Nucleoside diphosphate kinase A | PRO_0000137114 | |||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||||
| Active site | 118 | 1 | Pros-phosphohistidine intermediate Ref.2 | ||||||||||||||||||||||||||||||||||||
| Binding site | 12 | 1 | ATP | ||||||||||||||||||||||||||||||||||||
| Binding site | 60 | 1 | ATP | ||||||||||||||||||||||||||||||||||||
| Binding site | 88 | 1 | ATP | ||||||||||||||||||||||||||||||||||||
| Binding site | 94 | 1 | ATP | ||||||||||||||||||||||||||||||||||||
| Binding site | 105 | 1 | ATP | ||||||||||||||||||||||||||||||||||||
| Binding site | 115 | 1 | ATP | ||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||
| Modified residue | 94 | 1 | Phosphothreonine Ref.19 | ||||||||||||||||||||||||||||||||||||
| Cross-link | 100 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) Ref.17 | |||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 | 1 | M → MVLLSTLGIVFQGEGPPISS CDTGTM in isoform 2. | VSP_036707 | |||||||||||||||||||||||||||||||||||
| Natural variant | 120 | 1 | S → G in neuroblastoma; increased motility of carcinoma cells. | VAR_004625 | |||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 60 | 1 | F → W: No loss of activity or substrate binding. Ref.22 | ||||||||||||||||||||||||||||||||||||
| Mutagenesis | 96 | 1 | P → S: Increased motility of carcinoma cells. | ||||||||||||||||||||||||||||||||||||
| Mutagenesis | 118 | 1 | H → F: Loss of serine/threonine kinase activity. Some loss of motility of carcinoma cells. | ||||||||||||||||||||||||||||||||||||
| Mutagenesis | 118 | 1 | H → G: Loss of activity. Ref.22 | ||||||||||||||||||||||||||||||||||||
| Mutagenesis | 120 | 1 | S → A: Limited increase in motility of carcinoma cells. | ||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 6 – 11 | 6 | |||||||||||||||||||||||||||||||||||||
| Helix | 13 – 17 | 5 | |||||||||||||||||||||||||||||||||||||
| Helix | 21 – 31 | 11 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 34 – 41 | 8 | |||||||||||||||||||||||||||||||||||||
| Helix | 45 – 51 | 7 | |||||||||||||||||||||||||||||||||||||
| Helix | 53 – 55 | 3 | |||||||||||||||||||||||||||||||||||||
| Helix | 61 – 69 | 9 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 73 – 80 | 8 | |||||||||||||||||||||||||||||||||||||
| Helix | 83 – 91 | 9 | |||||||||||||||||||||||||||||||||||||
| Helix | 96 – 98 | 3 | |||||||||||||||||||||||||||||||||||||
| Helix | 104 – 108 | 5 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 117 – 119 | 3 | |||||||||||||||||||||||||||||||||||||
| Helix | 123 – 133 | 11 | |||||||||||||||||||||||||||||||||||||
| Helix | 136 – 138 | 3 | |||||||||||||||||||||||||||||||||||||
| Helix | 147 – 150 | 4 | |||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development." Rosengard A.M., Krutzsch H.C., Shearn A., Biggs J.R., Barker E., Margulies I.M.K., King C.R., Liotta L.A., Steeg P.S. Nature 342:177-180(1989) [PubMed: 2509941] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [2] | "Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme." Gilles A.-M., Presecan E., Vonica A., Lascu I. J. Biol. Chem. 266:8784-8789(1991) [PubMed: 1851158] [Abstract] Cited for: PROTEIN SEQUENCE (ISOFORM 1), SUBUNIT, ACTIVE SITE. |
| [3] | "Mutation in the nm23 gene is associated with metastasis in colorectal cancer." Wang L., Patel U., Ghosh L., Chen H.C., Banerjee S. Cancer Res. 53:717-720(1993) [PubMed: 7916650] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [4] | "Isolation and characterization of the human genomic locus coding for the putative metastasis control gene nm23-H1." Dooley S., Seib T., Engel M., Theisinger B., Janz H., Piontek K., Zang K.D., Welter C. Hum. Genet. 93:63-66(1994) [PubMed: 8270257] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1). |
| [5] | "Isolation and characterization of a novel human NM23-H1B gene, a different transcript of NM23-H1." Ni X., Gu S., Dai J., Cheng H., Guo L., Li L., Ji C., Xie Y., Ying K., Mao Y. J. Hum. Genet. 48:96-100(2003) [PubMed: 12601555] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY. |
| [6] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). |
| [7] | "Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)." Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y., LaBaer J. Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). |
| [8] | "DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage." Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R., Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A., Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J., Chang J.L. Nusbaum C.Nature 440:1045-1049(2006) [PubMed: 16625196] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [9] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [10] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Brain and Lung. |
| [11] | "High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification." Hailat N., Keim D.R., Melhem R.F., Zhu X.X., Eckerskorn C., Brodeur G.M., Reynolds C.P., Seeger R.C., Lottspeich F., Strahler J.R., Hanash S.J. J. Clin. Invest. 88:341-345(1991) [PubMed: 2056128] [Abstract] Cited for: PROTEIN SEQUENCE OF 7-18; 40-49 AND 89-94 (ISOFORMS 1/2), DISEASE. |
| [12] | Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y. Submitted (DEC-2008) to UniProtKB Cited for: PROTEIN SEQUENCE OF 7-26; 40-49; 57-85 AND 89-128 (ISOFORMS 1/2), MASS SPECTROMETRY. Tissue: Brain, Cajal-Retzius cell and Fetal brain cortex. |
| [13] | "Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells." MacDonald N.J., Freije J.M., Stracke M.L., Manrow R.E., Steeg P.S. J. Biol. Chem. 271:25107-25116(1996) [PubMed: 8810265] [Abstract] Cited for: FUNCTION, MUTAGENESIS OF PRO-96; HIS-118 AND SER-120. |
| [14] | "Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display." Manda R., Kohno T., Matsuno Y., Takenoshita S., Kuwano H., Yokota J. Genomics 61:5-14(1999) [PubMed: 10512675] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [15] | "Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor." Fan Z., Beresford P.J., Oh D.Y., Zhang D., Lieberman J. Cell 112:659-672(2003) [PubMed: 12628186] [Abstract] Cited for: FUNCTION, ENZYME REGULATION, INTERACTION WITH SET. |
| [16] | "Read-through transcript from NM23-H1 into the neighboring NM23-H2 gene encodes a novel protein, NM23-LV." Valentijn L.J., Koster J., Versteeg R. Genomics 87:483-489(2006) [PubMed: 16442775] [Abstract] Cited for: ALTERNATIVE SPLICING (ISOFORM 3), SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [17] | "Quantitative analysis of global ubiquitination in HeLa cells by mass spectrometry." Meierhofer D., Wang X., Huang L., Kaiser P. J. Proteome Res. 7:4566-4576(2008) [PubMed: 18781797] [Abstract] Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-100, MASS SPECTROMETRY. |
| [18] | "Phosphorylation of nm23-H1 by CKI induces its complex formation with h-prune and promotes cell motility." Garzia L., D'Angelo A., Amoresano A., Knauer S.K., Cirulli C., Campanella C., Stauber R.H., Steegborn C., Iolascon A., Zollo M. Oncogene 27:1853-1864(2008) [PubMed: 17906697] [Abstract] Cited for: INTERACTION WITH PRUNE. |
| [19] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-94, MASS SPECTROMETRY. |
| [20] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [21] | "Crystal structure of human nucleoside diphosphate kinase A, a metastasis suppressor." Min K., Song H.K., Chang C., Kim S.Y., Lee K.J., Suh S.W. Proteins 46:340-342(2002) [PubMed: 11835509] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS). |
| [22] | "Nucleotide binding to nucleoside diphosphate kinases: X-ray structure of human NDPK-A in complex with ADP and comparison to protein kinases." Chen Y., Gallois-Montbrun S., Schneider B., Veron M., Morera S., Deville-Bonne D., Janin J. J. Mol. Biol. 332:915-926(2003) [PubMed: 12972261] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS), MUTAGENESIS OF PHE-60 AND HIS-118. |
| [23] | "Nm23-H1 mutation in neuroblastoma." Chang C.L., Zhu X.-X., Thoraval D.H., Ungar D., Rawwas J., Hora N., Strahler J.R., Hanash S.M. Nature 370:335-336(1994) [PubMed: 8047138] [Abstract] Cited for: VARIANT NEUROBLASTOMA GLY-120. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| X17620 mRNA. Translation: CAA35621.1. Different initiation. X73066 mRNA. Translation: CAA51527.1. X75598 Genomic DNA. Translation: CAA53270.1. AF487339 mRNA. Translation: AAO85436.1. AK291105 mRNA. Translation: BAF83794.1. CR542104 mRNA. Translation: CAG46901.1. CR542115 mRNA. Translation: CAG46912.1. AC005839 Genomic DNA. No translation available. CH471109 Genomic DNA. Translation: EAW94568.1. BC000293 mRNA. Translation: AAH00293.1. BC018994 mRNA. Translation: AAH18994.1. | |||||||||||||||||||||||||||||||
| IPI | IPI00012048. IPI00375531. | ||||||||||||||||||||||||||||||
| PIR | A33386. | ||||||||||||||||||||||||||||||
| RefSeq | NP_000260.1. NP_937818.1. | ||||||||||||||||||||||||||||||
| UniGene | Hs.463456 | ||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||
| IntAct | P15531. 13 interactions. | ||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||
| PhosphoSite | P15531. | ||||||||||||||||||||||||||||||
2-D gel databases | |||||||||||||||||||||||||||||||
| Aarhus/Ghent-2DPAGE | 4115. IEF. 5112. IEF. | ||||||||||||||||||||||||||||||
| DOSAC-COBS-2DPAGE | P15531. | ||||||||||||||||||||||||||||||
| OGP | P15531. | ||||||||||||||||||||||||||||||
| PMMA-2DPAGE | P15531. | ||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||
| PRIDE | P15531. | ||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||
| Ensembl | ENSG00000011052. Homo sapiens. [Contig view] | ||||||||||||||||||||||||||||||
| GeneID | 4830. | ||||||||||||||||||||||||||||||
| KEGG | hsa:4830. | ||||||||||||||||||||||||||||||
| NMPDR | fig|9606.3.peg.14075. fig|9606.3.peg.14076. | ||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||
| GeneCards | GC17P046585. GC17P046586. | ||||||||||||||||||||||||||||||
| HGNC | HGNC:7849. NME1. | ||||||||||||||||||||||||||||||
| HPA | CAB002169. HPA008467. | ||||||||||||||||||||||||||||||
| MIM | 156490. gene. | ||||||||||||||||||||||||||||||
| Orphanet | 635. Neuroblastoma. | ||||||||||||||||||||||||||||||
| PharmGKB | PA249. | ||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||
| HOVERGEN | P15531. | ||||||||||||||||||||||||||||||
| OMA | P15531. YDELCEF. | ||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||
| BRENDA | 2.7.4.6. 247. | ||||||||||||||||||||||||||||||
| Pathway_Interaction_DB | arf6downstreampathway. Arf6 downstream pathway. arf6_traffickingpathway. Arf6 trafficking events. | ||||||||||||||||||||||||||||||
| Reactome | REACT_1698. Nucleotide metabolism. | ||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||
| ArrayExpress | P15531. | ||||||||||||||||||||||||||||||
| Bgee | P15531. | ||||||||||||||||||||||||||||||
| CleanEx | HS_NME1. | ||||||||||||||||||||||||||||||
| GermOnline | ENSG00000011052. Homo sapiens. | ||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||
| InterPro | IPR001564. Nuc_diP_kinase_core. [Graphical view] | ||||||||||||||||||||||||||||||
| Gene3D | G3DSA:3.30.70.141. NDK. 1 hit. | ||||||||||||||||||||||||||||||
| PANTHER | PTHR11349. Nuc_diP_kinase_core. 1 hit. | ||||||||||||||||||||||||||||||
| Pfam | PF00334. NDK. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| PRINTS | PR01243. NUCDPKINASE. | ||||||||||||||||||||||||||||||
| ProDom | PD001018. NDK. 1 hit. [Graphical view] [Entries sharing at least one domain] | ||||||||||||||||||||||||||||||
| SMART | SM00562. NDK. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| PROSITE | PS00469. NDP_KINASES. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||
Other Resources | |||||||||||||||||||||||||||||||
| DrugBank | DB00441. Gemcitabine. DB00396. Progesterone. | ||||||||||||||||||||||||||||||
| NextBio | 18606. | ||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||
Entry information
| Entry name | NDKA_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P15531 Secondary accession number(s): Q6FGK3, Q86XQ2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 17 Human chromosome 17: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |
| Recent format changes Overview of recent format changes |

Clusters with


